The hepatitis A virus (HAV) is a leading cause of acute viral hepatitis worldwide. It is
transmitted mainly by direct contact with patients who have been infected or by ingesting …

Background A life-course immunization approach would enhance the quality of life across
all age groups and improve societal well-being. The herpes zoster (HZ) vaccine is highly …

With recent findings connecting the Epstein-Barr virus to an increased risk of multiple
sclerosis and growing concerns regarding the neurological impact of the coronavirus …

Chronic hepatitis B virus (HBV) infection can lead to substantial morbidity and mortality.
Although treatment is not considered curative, antiviral treatment, monitoring, and liver …

Background Hepatitis B is a vaccine-preventable, communicable disease of the liver caused
by HBV. HBV is transmitted through percutaneous (ie, puncture through the skin) or mucosal …

This report compiles and summarizes all published recommendations from CDC's Advisory
Committee on Immunization Practices (ACIP) for use of pneumococcal vaccines in adults …

Objective This consensus statement provides (1) visual guidance in concise graphic
algorithms to assist with clinical decision-making of health care professionals in the …

Abstract On February 2, 2022, President Biden and First Lady Dr. Biden reignited the Cancer
Moonshot, setting a new goal to reduce age-standardized cancer mortality rates by at least …

Background: Human papillomavirus (HPV) vaccination was introduced in 2006 for females
and in 2011 for males. Objective: To estimate vaccine impact and effectiveness against …

Patients with chronic liver disease (CLD) with or without cirrhosis remain at risk of
developing hepatic decompensation when infected with viral or bacterial pathogens. The …